Back

DYNAMIC - Riociguat in patients with pulmonary hypertension and heart failure with preserved ejection fraction

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Latest Science in Heart Failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Diana Bondermann

Favoriten Clinic, Vienna (Austria)

8 More presentations in this session

Presentation thumbnail
EmDia - Empagliflozin and left ventricular diastolic function
Doctor P. Wild (Mainz, DE)
Slides Video
Presentation thumbnail
High-sensitivity cardiac troponin in DAPA-HF
Doctor D. Berg (Boston, US)
Slides Video
Presentation thumbnail
Gestational hypertensive disorders in PPCM.
Doctor A. Jackson (Glasgow, GB)
Slides Video
Presentation thumbnail
The HUNT for HF risk score
Doctor A. Ofstad (Gjettum, NO)
Slides Video
Presentation thumbnail
Efficacy of ARNI in real-world
Professor M. Fu (Gothenburg, SE)
Slides Video

Access the full session

Session thumbnail
Latest Science in Heart Failure

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources